Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new aerosol device for bronchial provocation tests

H Matthys1, M Knoch, R Eltschka

  • 1Department of Internal Medicine, University Hospital, Freiburg, FRG.

Respiration; International Review of Thoracic Diseases
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of the effect of pharmacotherapy in common cold/acute bronchitis - the Bronchitis Severity Scale (BSS).

Pneumologie (Stuttgart, Germany)·2014
Same author

Symbols, abbreviations and units.

The European respiratory journal·2014
Same author

Positioning of the Bronchitis Severity Score (BSS) for standardised use in clinical studies.

Current medical research and opinion·2013
Same author

Efficacy and tolerability of EPs 7630 tablets in patients with acute bronchitis: a randomised, double-blind, placebo-controlled dose-finding study with a herbal drug preparation from Pelargonium sidoides.

Current medical research and opinion·2010
Same author

Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomised, double-blind, placebo-controlled, multicentre study.

Current medical research and opinion·2007
Same author

Pelargonium sidoides preparation (EPs 7630) in the treatment of acute bronchitis in adults and children.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2006

A novel device improves aerosol delivery for lung diagnostics and therapy. This system enhances pulmonary deposition ten times, enabling precise dosing for conditions like asthma provocation and treatment.

Area of Science:

  • Pulmonary Medicine
  • Medical Device Technology
  • Pharmacology

Background:

  • Accurate aerosol delivery is crucial for lung diagnostics and therapeutics.
  • Existing nebulizer systems often lack standardization, impacting dose-response assessments.
  • The Pari Provocation Test I is a new device designed to overcome these limitations.

Purpose of the Study:

  • To describe a new device for standardized diagnostic and therapeutic aerosol application.
  • To evaluate its efficiency in enhancing pulmonary aerosol deposition.
  • To highlight its utility in dose-response studies and precise aerosol therapy.

Main Methods:

  • A high-quality nebulizer system integrated with a 10-liter storage bag was developed.
  • The storage bag acts as an aerosol conditioner and holding chamber.

Related Experiment Videos

  • Slow inspiratory vital capacity maneuvers were employed for aerosol delivery.

    • Main Results:

    • The device achieves approximately 100 mg of aerosol deposition in children and adults.
    • It provides ten times greater standardized pulmonary aerosol deposition compared to conventional nebulizers.
    • This facilitates accurate dose-response curve calculations for provocation and dilatation tests.

    Conclusions:

    • The described device offers superior, standardized aerosol deposition for lung applications.
    • It is particularly valuable for precise dosing in diagnostic (e.g., asthma provocation) and therapeutic aerosol delivery.
    • This innovation supports the expanding field of topical and systemic aerosol treatments via the lung.